前收市價 | 22.50 |
開市 | 22.80 |
買盤 | 23.24 x 1000 |
賣出價 | 23.31 x 1000 |
今日波幅 | 22.37 - 23.36 |
52 週波幅 | 19.37 - 47.48 |
成交量 | |
平均成交量 | 1,483,719 |
市值 | 2.244B |
Beta 值 (5 年,每月) | 1.80 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -5.42 |
業績公佈日 | 2024年5月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 70.96 |
On Intellia's (NTLA) first-quarter 2024 earnings call, investors' focus is likely to be on the progress of its pipeline of genome-editing candidates.
Intellia Therapeutics (NTLA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.